Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...

Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced that Edward "Ted" Ruppel, President and CEO, is scheduled to speak on Wednesday, March 19th, ...

Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...

The Basant Utsav continues to be a cherished cultural celebration, bringing together the people of Panchkula to welcome ...

Delegates will explore AI’s use cases, how to determine the true ROI of AI and examine how to ensure AI solutions are ...

Shilpa Medicare has launched a new full service ‘hybrid’ CDMO with oncology as a particular therapeutic specialty.

WuXi Biologics passes GMP inspection by Japan PMDA for its drug substance facilities in Wuxi city: Wuxi, China Friday, February 28, 2025, 15:00 Hrs [IST] WuXi Biologics (WuXi Bio) ...

and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its drug substance facilities (MFG2 ...

and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its drug substance facilities ...

The global stem cell therapy market is poised for remarkable growth, with revenues projected to escalate from USD 394.50 million in 2024 to USD 2,612.92 million by 2033, reflecting a compelling ...

Q4 2024 Earnings Call Transcript March 6, 2025 Arcturus Therapeutics Holdings Inc. misses on earnings expectations. Reported ...